Bradley Mason - Orthofix Medical CEO and President and Director
OFIX Stock | USD 13.00 0.09 0.69% |
CEO
Mr. Bradley R. Mason is President, Chief Executive Officer, Director of the Company. Mr. Mason has served as a director since the Companys 2013 annual general meeting of shareholders. Mr. Mason rejoined Orthofix in March 2013 as our President and Chief Executive Officer after previously serving as Group President, North America from June 2008 through October 2009, and as a Strategic Advisor from November 2009 through October 2010. Prior to being appointed as Group President, North America, he had served as a Vice President of the Company since December 2003, when the Company acquired Breg, Inc. Prior to its acquisition by Orthofix, Mr. Mason had served as President and Chairman of Breg, a company he principally founded in 1989 with five other shareholders. Mr. Mason has over 30 years of experience in the medical device industry, some of which were spent with dj Orthopedics where he became an owner and executive in its early development stage and held the position of Executive Vice President. Following his retirement from Orthofix in 2010, he served in a variety of parttime consulting and advisory roles, including as a consultant to Orthofix since October 2012, which consulting relationship terminated as of March 13, 2013 when he rejoined Orthofix. Mr. Mason is the named inventor on 38 issued patents in the orthopedic product arena. He graduated Summa Cum Laude with an Associate of Arts and Associate of Science degree from MiraCosta College. since 2013.
Age | 63 |
Tenure | 11 years |
Address | 3451 Plano Parkway, Lewisville, TX, United States, 75056 |
Phone | 214 937 2000 |
Web | https://www.orthofix.com |
Orthofix Medical Management Efficiency
The company has return on total asset (ROA) of (0.063) % which means that it has lost $0.063 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3236) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.23 in 2024. Return On Capital Employed is likely to rise to -0.18 in 2024. At this time, Orthofix Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 530.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 20.9 M in 2024.Similar Executives
Found 2 records | CEO Age | ||
Samuel Hazen | HCA Holdings | 64 | |
Debra Osteen | Acadia Healthcare | 62 |
Management Performance
Return On Equity | -0.32 | ||||
Return On Asset | -0.063 |
Orthofix Medical Leadership Team
Elected by the shareholders, the Orthofix Medical's board of directors comprises two types of representatives: Orthofix Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthofix. The board's role is to monitor Orthofix Medical's management team and ensure that shareholders' interests are well served. Orthofix Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthofix Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Paolucci, Independent Director | ||
Rice Doug, CFO | ||
Doug Rice, Interim CFO, Chief Accounting Officer | ||
Lucas Vitale, Chief Officer | ||
Frank Vizesi, Chief Officer | ||
Julie Andrews, Chief Officer | ||
Roberto Donadello, Senior Operations | ||
Jeffrey Schumm, Chief Admin. Officer, General Counsel and Corporate Secretary | ||
Mark Quick, Sr Relations | ||
Tyler Lipschultz, President Biologics | ||
Dan Yarbrough, Vice Relations | ||
James Hinrichs, Independent Director | ||
BA Chemistry, Chief Officer | ||
Kimberley Elting, President Orthopedics | ||
Bradley Mason, CEO and President and Director | ||
Robert Goodwin, President - Biologics | ||
Alexis Lukianov, Independent Director | ||
Raymond Fujikawa, President - Spine Fixation | ||
Davide Bianchi, President of Global Extremity Fixation | ||
Anthony Martin, Independent Director | ||
Ehab Esmail, Regulatory Quality | ||
Guy Jordan, Independent Director | ||
Suzanne Armstrong, Chief Officer | ||
Bradley Niemann, President - BioStim | ||
Douglas Rice, CFO Officer | ||
Jon Serbousek, President - Global Spine Business | ||
Jill Mason, Interim Counsel | ||
Michael Finegan, Chief Strategy Officer | ||
Ronald Matricaria, Independent Chairman of the Board | ||
Maria Sainz, Independent Director | ||
Lilly Marks, Director | ||
Kevin Kenny, President Business | ||
John Sicard, Independent Director | ||
Luke Faulstick, Director | ||
Massimo Calafiore, CEO President |
Orthofix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthofix Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.32 | ||||
Return On Asset | -0.063 | ||||
Profit Margin | (0.20) % | ||||
Operating Margin | (0.02) % | ||||
Current Valuation | 590.74 M | ||||
Shares Outstanding | 37.41 M | ||||
Shares Owned By Insiders | 3.52 % | ||||
Shares Owned By Institutions | 96.25 % | ||||
Number Of Shares Shorted | 3.78 M | ||||
Price To Earning | 338.00 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Orthofix Stock analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Orthofix Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthofix Medical. If investors know Orthofix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthofix Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.12) | Revenue Per Share 20.328 | Quarterly Revenue Growth 0.64 | Return On Assets (0.06) | Return On Equity (0.32) |
The market value of Orthofix Medical is measured differently than its book value, which is the value of Orthofix that is recorded on the company's balance sheet. Investors also form their own opinion of Orthofix Medical's value that differs from its market value or its book value, called intrinsic value, which is Orthofix Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthofix Medical's market value can be influenced by many factors that don't directly affect Orthofix Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthofix Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthofix Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthofix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.